Stay updated with breaking news from Cassava Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Overactive mTOR Plays a Key Role in Aging and Alzheimer’s Disease.Simufilam Suppresses Overactive mTOR, Suggesting a Beneficial Drug Effect.Research is Published in Frontiers in Aging, a Peer-reviewed Journal. AUSTIN, Texas, June 27, 2023 (GLOBE ...
NEW ORLEANS, June 24, 2023 (GLOBE NEWSWIRE) -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick...
NEW ORLEANS, June 24, 2023 (GLOBE NEWSWIRE) -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC
Shares of Cassava Sciences, Inc. (NASDAQ:SAVA – Get Rating) rose 4.7% on Wednesday . The company traded as high as $25.92 and last traded at $25.91. Approximately 343,126 shares were traded during mid-day trading, a decline of 65% from the average daily volume of 972,789 shares. The stock had previously closed at $24.74. Wall Street […]
Publication Reviews Certain Receptor-Protein Interactions. Provides Overview of Basic Science Supporting Simufilam. Published in Drug Development Research, a Peer-Reviewed Journal. AUSTIN, Texas,... | June 12, 2023